Table 3.
Genotype and eGFR slope quartiles
Males |
Females |
|||||||
eGFR slope Quartile 1 (−1.2 to +5.3), N = 38 | eGFR slope Quartile 2 (−2.8 to −1.3), N = 38 | eGFR slope Quartile 3 (−4.8 to −2.9), N = 38 | eGFR slope Quartile 4 (−15.5 to −4.9), N = 37 | eGFR slope Quartile 1 (+1.1 to +7.5), N = 15 | eGFR slope Quartile 2 (−0.4 to +1.0), N = 16 | eGFR slope Quartile 3 (−2.3 to −0.4), N = 16 | eGFR slope Quartile 4 (−7.6 to −2.4), N = 15 | |
Mutation type, n (%)a | ||||||||
Nonsense | 3 (18.8) | 1 (3.6) | 5 (31.3) | 7 (43.8) | 3 (23.1) | 3 (23.1) | 2 (15.4) | 5 (38.5) |
Missense | 23 (32.4) | 21 (29.6) | 15 (21.1) | 12 (16.9) | 5 (17.2) | 10 (34.5) | 9 (31.0) | 5 (17.2) |
Splice site | 0 | 2 (40.0) | 2 (40.0) | 1 (20.0) | 0 | 0 | 1 (50.0) | 1 (50.0) |
Frameshift | 3 (25.0) | 2 (16.7) | 4 (33.3) | 3 (25.0) | 3 (50.0) | 3 (50.0) | 0 | 0 |
Intronic | 0 | 1 (100.0) | 0 | 0 | 0 | 0 | 0 | 0 |
Initiator codon | 0 | 1 (100.0) | 0 | 0 | 0 | 0 | 0 | 0 |
Small deletion (no frameshift) | 2 (66.7) | 1 (33.3) | 0 | 0 | 0 | 0 | 0 | 0 |
Small insertion (no frameshift) | 0 | 0 | 0 | 0 | 0 | 0 | 1 (100.0) | 0 |
Other | 0 | 0 | 0 | 1 (100.0) | 0 | 0 | 1 (100.0) | 0 |
Not available | 7 (17.1) | 9 (22.0) | 12 (29.3) | 13 (31.7) | 4 (40.0) | 0 | 2 (20.0) | 4 (40.0) |
Five most prevalent missense genotypes, n (%)b | ||||||||
N215S | 2 (2.8) | 1 (1.4) | 2 (2.8) | 0 | 0 | 0 | 0 | 1 (3.4) |
L415P | 4 (5.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R301Q | 2 (2.8) | 2 (2.8) | 0 | 0 | 0 | 0 | 0 | 0 |
P259R | 1 (1.4) | 0 | 0 | 1 (1.4) | 1 (3.4) | 1 (3.4) | 0 | 0 |
C52G | 1 (1.4) | 0 | 0 | 0 | 0 | 2 (6.9) | 0 | 0 |
For mutation type, percentages were calculated based on the total number of patients with each type of mutation, by gender.
These five missense mutations (N215S, L415P, R301Q, P259R and C52G) were the only genotypes reported by more than two patients in this cohort. Percentages for these five genotypes were calculated based on the total number of patients who reported missense mutations, by gender (n = 71 men and n = 29 women).